"Centura Health is the largest health care ecosystem across Colorado and western Kansas, on a mission to support your whole health. Every community, every neighborhood, every life – whole and healthy."

During the past decade, Penrose Cancer Center at Penrose Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 66 clinical trials were completed, i.e. on average, 6600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Penrose Cancer Center at Penrose Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 43 trials, followed by "Eastern Cooperative Oncology Group" with 22 trials sponsored, "Radiation Therapy Oncology Group" with 13 trials sponsored, "NSABP Foundation Inc" with 9 trials sponsored and "SWOG Cancer Research Network" with 9 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Penrose Cancer Center at Penrose Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 100 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "NCIC Clinical Trials Group" with 4 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Penrose Cancer Center at Penrose Hospital" are "Breast Cancer" (26 trials), "Lung Cancer" (16 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (14 trials), "Leukemia" (11 trials) and "Lymphoma" (10 trials). Many other conditions were trialed in "Penrose Cancer Center at Penrose Hospital" in a lesser frequency.

Most popular intervention types in "Penrose Cancer Center at Penrose Hospital" are "Drug" (91 trials), "Biological" (34 trials), "Other" (32 trials), "Radiation" (29 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (23 trials), "cyclophosphamide" (11 trials), "bevacizumab" (10 trials), "gemcitabine hydrochloride" (8 trials) and "doxorubicin hydrochloride" (7 trials). Other intervention names were less common.

The vast majority of trials in "Penrose Cancer Center at Penrose Hospital" are 91 trials for "All" genders, 18 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Penrose Cancer Center at Penrose Hospital". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Penrose Cancer Center at Penrose Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Penrose Cancer Center at Penrose Hospital, 2 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".